ALFA Finder| Revenue growth | FY25: 4% YoY degrowth; Q4: 22% YoY growth. |
|---|---|
| Margins | Consolidated FY25 EBITDA margin 28%; PAT margin 11%. |
| Order book | Recent LOIs/Contracts signed total ₹14,646 Crores. |
| Demand visibility | H2 recovery signs; sales increasing both YoY and sequentially. |
| Management confidence | Confident in returning to historical growth rates. |
Growth
Q4 revenue grew 22% YoY and 31% QoQ. Consolidated FY25 EBITDA at ₹4,123 Mn (28% margin); PAT at ₹1,600 Mn.
Outlook
Strong order book of ₹14,646 Cr; targeting $220-260Mn revenue potential from fluorination. Strategic focus on Pharma and Polymers.
Risks
Subdued H1 FY25 due to weak macro conditions; high finance costs (₹1,122 Mn in FY25 vs ₹894 Mn in FY24).
Earnings Call filed with NSE, NSE: ANURAS. Summary written with AI assistance from the document.
Anupam Rasayan India Ltd: key numbers
- Share price
- ₹1,196.20
- Market cap
- ₹13,619 Cr
- Revenue (annual)
- ₹2,365 Cr
- Net profit (annual)
- ₹170.1 Cr
- P/E (TTM)
- 75.5×Sector 35.5×
- Promoter holding
- 59.07%+0.00% QoQ
- FII holding
- 8.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anupam Rasayan India Ltd
All →Anupam Rasayan India Earnings Call Transcript: Key Takeaways
Q2 income up 11% to ₹821 Cr; EBITDA up 41% to ₹202 Cr at 25% margin. Bliss GVS closed 28 Sep, so only three days are consolidated. Management avoided quantifying Bliss and M&A.
Anupam Rasayan India Investor Presentation: Key Takeaways
Q2FY27 consolidated total income ₹821 Cr (+11% YoY), EBITDA ₹202 Cr (+41%, 25% margin), PAT ₹65 Cr (+14%). Controlling stake in Bliss GVS Pharma acquired 28 Sep 2026.
Anupam Rasayan India Q2 FY27 Results: Net Profit ₹65 Cr, Up 13.6% YoY
Anupam Rasayan India Ltd reported revenue from operations of ₹805.9 Cr (+10.2% YoY) and net profit of ₹65 Cr (+13.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65 Cr · +13.6% YoY
Anupam Rasayan India Board Meeting Date
Anupam Rasayan India scheduled a November 6, 2026 board meeting to approve unaudited standalone and consolidated results. The trading window stays closed until November 8.
Anupam Rasayan India Annual General Meeting
Anupam Rasayan India Limited filed copy of minutes of its Annual General Meeting held on September 30, 2026. The filing is procedural and carries no financial or business event.
Anupam Rasayan India Other Announcement
Anupam Rasayan India disclosed a Crisil ESG rating of 62 and Core ESG rating of 63 (Strong). No transaction or business decision is involved.